537MO First-in-human study of JNJ-64619178, a protein arginine methyltransferase 5 (PRMT5) inhibitor, in patients with advanced cancers
Anna Spreafico,
Víctor Moreno,
Irene Braña,
Tatiana Hernández,
Albiruni Abdul Razak,
J. Wang,
Nahor Haddish‐Berhane,
Jaydeep Mehta,
Amy J. Johnson,
Anke Maes,
Annals of Oncology · 2020 · 31 citations · 0 references